Eversept Partners, LP

13F Filings History

Latest 13F report
Q3 2024 - Nov 14, 2024
Value $
$1.3B
Signature - Title
Ron Rosenstraus - Chief Financial Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by Eversept Partners, LP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Eversept Partners, LP reported 65 stock holdings with total value $1.3B as of Q3 2024. Top holdings included GSK, NTRA, VERA, INSM, and SNDX.
Holdings Value